Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves

16 references·5 citing·24 second hop

FromToDepth

this work references cited by second hop

References

2003The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)1,271 cited
1998Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings658 cited
1987Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.530 cited
2000Ecstasy (MDMA): a review of its possible persistent psychological effects380 cited
1985Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals367 cited
2001Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research344 cited
2002Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity325 cited
2000(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals292 cited
2000Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users279 cited
2001Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies236 cited
2001Cognitive performance and serotonergic function in users of ecstasy233 cited
2001Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems210 cited
2000(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies188 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1998

An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

181 cited

2002Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users181 cited

19993,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans178 cited

Cited by

2006MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress139 cited
2013MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users118 cited
2007The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review87 cited
2008Dance Clubbing on MDMA and during Abstinence from Ecstasy/MDMA: Prospective Neuroendocrine and Psychobiological Changes77 cited
2009Variaciones en el uso de substancias entre clubbers de acuerdo con factores individuales y de nivel de escena9 cited